To bleed or not to bleed - is that a question?
Aledort
L M
LM
Mount Sinai School of Medicine, New York, NY, USA. louis.aledort@mssm.edu
D003029:Coagulants / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005169:Factor VIII / Q000008:administration & dosage* / Q000009:adverse effects; D006395:Hemarthrosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006467:Hemophilia A / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D018718:Home Infusion Therapy; D006801:Humans; D007262:Infusions, Intravenous; D055502:Secondary Prevention; D012720:Severity of Illness Index; D013395:Sucrose / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome
D003029:Coagulants; C438308:recombinant FVIII, sugar formulated; D013395:Sucrose; D005169:Factor VIII